Use of multikinase inhibitors/lenvatinib concomitant with antiresorptive therapy for bone metastases from radioiodine‐resistant differentiated thyroid cancer

MLA

Elena Navarro‐Gonzalez. “Use of Multikinase Inhibitors/Lenvatinib Concomitant with Antiresorptive Therapy for Bone Metastases from Radioiodine‐resistant Differentiated Thyroid Cancer.” Cancer Medicine, vol. 11, no. S1, Oct. 2022, pp. 54–58. EBSCOhost, https://doi.org/10.1002/cam4.4983.

APA

Elena Navarro‐Gonzalez. (2022). Use of multikinase inhibitors/lenvatinib concomitant with antiresorptive therapy for bone metastases from radioiodine‐resistant differentiated thyroid cancer. Cancer Medicine, 11(S1), 54–58. https://doi.org/10.1002/cam4.4983

Chicago

Elena Navarro‐Gonzalez. 2022. “Use of Multikinase Inhibitors/Lenvatinib Concomitant with Antiresorptive Therapy for Bone Metastases from Radioiodine‐resistant Differentiated Thyroid Cancer.” Cancer Medicine 11 (S1): 54–58. doi:10.1002/cam4.4983.